After failing to grab investors' attention for quite some time, Lululemon Athletica Inc. LULU seems to have gained traction. The stock, which slipped to a 52-week low in May, posted upbeat performances in the past two quarters on strategies like ivivva's remodeling and focus on e-commerce among others. Notably, this yoga-apparel company has surged 22.4% in the past six months, surpassing the industry's 9.9% growth.
The solid second quarter and favorable third-quarter trends make management confident of generating revenues of $4 billion by 2020. These factors also encouraged Lululemon to raise fiscal 2017 outlook. Analysts were also not far behind in raising the estimates. Over the past 60 days, the Zacks Consensus Estimate for fiscal 2017 and 2018 increased to $2.43 and $2.72 from $2.34 to $2.67, respectively. Given these splendid strategies and an impressive outlook, we believe that there is no looking back for Lululemon.
Looking for Similar Bets? Check These 3 Stocks From Lululemon's Space
Crocs, Inc. CROX, with a long-term earnings per share growth rate of 15%, sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
G-III Apparel Group, Ltd. GIII flaunts the same Zacks Rank and long-term growth rate as Crocs.
Guess', Inc. GES with long-term growth rate of 17.5%, also flaunts a Zacks Rank #1.
Wall Street's Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It's a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
lululemon athletica inc. LULU: Free Stock Analysis Report
Guess?, Inc. GES: Free Stock Analysis Report
Crocs, Inc. CROX: Free Stock Analysis Report
G-III Apparel Group, LTD. GIII: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.